Similar articles

• Effects of omega-aminoacids and clot formation on the activation by urokinase of various plasminogen preparations.

  Takada A, Takada Y. Takada A, et al. Thromb Res. 1980 Apr 1-15;18(1-2):167-76. doi: 10.1016/0049-3848(80)90181-4. Thromb Res. 1980. PMID: 6773180 No abstract available.
• Influence of dextran sulfate and tranexamic acid on the activation of plasminogen by urokinase.

  Takada Y, Takada A. Takada Y, et al. Thromb Res. 1979;16(5-6):865-9. doi: 10.1016/0049-3848(79)90232-9. Thromb Res. 1979. PMID: 160629 No abstract available.
• Conversion of proteolytically modified form (Lys-form) of human plasminogen to plasmin by urokinase in the presence of tranexamic acid.

  Takada A, Takada Y. Takada A, et al. Thromb Res. 1981 Aug 15-Sep 1;23(4-5):411-9. doi: 10.1016/0049-3848(81)90202-4. Thromb Res. 1981. PMID: 6459659 No abstract available.
• [The enzymatic linkage of fibrinogenesis and fibrinolysis (author's transl)].

  Zimmermann RE, Lubinus J. Zimmermann RE, et al. Klin Wochenschr. 1978 Aug 15;56(16):781-8. doi: 10.1007/BF01489710. Klin Wochenschr. 1978. PMID: 211314 Review. German.
• Clinical pharmacology of tranexamic acid.

  Astedt B. Astedt B. Scand J Gastroenterol Suppl. 1987;137:22-5. Scand J Gastroenterol Suppl. 1987. PMID: 3321402 Review.